Evidence map›Paper›PMID 38970171›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Development and Application of Reversible and Irreversible Covalent Probes for Human and Mouse Cathepsin-K Activity Detection, Revealing Nuclear Activity.

Gourab Dey, Reut Sinai-Turyansky, Evalyn Yakobovich, Emmanuelle Merquiol, Jure Loboda, Nikhila Sridharan, Yael Houri-Haddad, David Polak, Simon Yona, Dusan Turk and 2 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gourab DeyThe Institute for Drug Research, The School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112001, Israel.
Reut Sinai-TuryanskyThe Institute for Drug Research, The School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112001, Israel.
Evalyn YakobovichThe Institute for Drug Research, The School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112001, Israel.
Emmanuelle MerquiolThe Institute for Drug Research, The School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112001, Israel.
Jure LobodaDepartment of Biochemistry, Molecular and Structural Biology, J. Stefan Institute, Ljubljana, SI-1000, Slovenia.
Nikhila SridharanThe Institute of Biomedical and Oral Research, The Faculty of Dental Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112001, Israel.
Yael Houri-HaddadDepartment of Prosthodontics, The Faculty of Dental Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112001, Israel.
David PolakDepartment of Prosthodontics, The Faculty of Dental Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112001, Israel.
Simon YonaThe Institute of Biomedical and Oral Research, The Faculty of Dental Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112001, Israel.
Dusan TurkDepartment of Biochemistry, Molecular and Structural Biology, J. Stefan Institute, Ljubljana, SI-1000, Slovenia.
Ori WaldDepartment of Cardiothoracic Surgery, Hadassah Hebrew University Medical Center, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112001, Israel.
Galia BlumThe Institute for Drug Research, The School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112001, Israel.ORCID 0000-0002-9374-2489

Funding

Israel Science Foundation 1638/19Teva Pharmaceutical Industries BIOINNOVETORS
6 · The paper itself

Abstract

Cathepsin-K (CTSK) is an osteoclast-secreted cysteine protease that efficiently cleaves extracellular matrices and promotes bone homeostasis and remodeling, making it an excellent therapeutic target. Detection of CTSK activity in complex biological samples using tailored tools such as activity-based probes (ABPs) will aid tremendously in drug development. Here, potent and selective CTSK probes are designed and created, comparing irreversible and reversible covalent ABPs with improved recognition components and electrophiles. The newly developed CTSK ABPs precisely detect active CTSK in mouse and human cells and tissues, from diseased and healthy states such as inflamed tooth implants, osteoclasts, and lung samples, indicating changes in CTSK's activity in the pathological samples. These probes are used to study how acidic pH stimulates mature CTSK activation, specifically, its transition from pro-form to mature form. Furthermore, this study reveals for the first time, why intact cells and cell lysate exhibit diverse CTSK activity while having equal levels of mature CTSK enzyme. Interestingly, these tools enabled the discovery of active CTSK in human osteoclast nuclei and in the nucleoli. Altogether, these novel probes are excellent research tools and can be applied in vivo to examine CTSK activity and inhibition in diverse diseases without immunogenicity hazards.

Indexed as

Cathepsin KAnimalsCell NucleusHumansMiceMolecular ProbesOsteoclastsCathepsin KMolecular Probesactivity‐based probescathepsin Kcovalent probesimaging protease activityproteases

Identifiers

PMID38970171
PMCPMC11481179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.